334 related articles for article (PubMed ID: 33720849)
1. Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a 'Treatabolome'.
Manta A; Spendiff S; Lochmüller H; Thompson R
J Neuromuscul Dis; 2021; 8(3):401-417. PubMed ID: 33720849
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
Missaglia S; Tavian D; Moro L; Angelini C
Lipids Health Dis; 2018 Nov; 17(1):254. PubMed ID: 30424791
[TBL] [Abstract][Full Text] [Related]
3. Two eminently treatable genetic metabolic myopathies.
Yee WC
Neurol India; 2008; 56(3):333-8. PubMed ID: 18974560
[TBL] [Abstract][Full Text] [Related]
4. Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report.
Goh LL; Lee Y; Tan ES; Lim JSC; Lim CW; Dalan R
BMC Med Genomics; 2018 Apr; 11(1):37. PubMed ID: 29615056
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of metabolic myopathies.
Angelini C
Biochim Biophys Acta; 2015 Apr; 1852(4):615-21. PubMed ID: 24997454
[TBL] [Abstract][Full Text] [Related]
6. [New approaches for the treatment of metabolic myopathies].
Laforêt P; Nicolino M; Eymard B
Rev Neurol (Paris); 2007 Oct; 163(10):930-5. PubMed ID: 18033029
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic advances in the management of Pompe disease and other metabolic myopathies.
Angelini C; Nascimbeni AC; Semplicini C
Ther Adv Neurol Disord; 2013 Sep; 6(5):311-21. PubMed ID: 23997816
[TBL] [Abstract][Full Text] [Related]
8. Treatment Opportunities in Patients With Metabolic Myopathies.
Ørngreen MC; Vissing J
Curr Treat Options Neurol; 2017 Sep; 19(11):37. PubMed ID: 28932990
[TBL] [Abstract][Full Text] [Related]
9. Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency.
Yıldız Y; Talim B; Haliloglu G; Topaloglu H; Akçören Z; Dursun A; Sivri HS; Coşkun T; Tokatlı A
Pediatr Neurol; 2019 Oct; 99():69-75. PubMed ID: 31331668
[TBL] [Abstract][Full Text] [Related]
10. The presence of white cell Jordan's anomaly in multiple Acyl-CoA dehydrogenase deficiency: A case report and implications for clinical practice.
Liu J; Ni W; Deng K; Chen Y; Gu G
Clin Biochem; 2024 Mar; 125():110735. PubMed ID: 38401771
[TBL] [Abstract][Full Text] [Related]
11. Two cases of glutaric aciduria type II: how to differentiate from inflammatory myopathies?
Koca M; Erden A; Armagan B; Sari A; Yildiz F; Ozdamar S; Kalyoncu U; Karadag O
Acta Clin Belg; 2019 Dec; 74(6):451-455. PubMed ID: 30451603
[TBL] [Abstract][Full Text] [Related]
12. Fulminant lipid storage myopathy due to multiple acyl-coenzyme a dehydrogenase deficiency.
Whitaker CH; Felice KJ; Silvers D; Wu Q
Muscle Nerve; 2015 Aug; 52(2):289-93. PubMed ID: 25556768
[TBL] [Abstract][Full Text] [Related]
13. Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations.
Chen W; Zhang Y; Ni Y; Cai S; Zheng X; Mastaglia FL; Wu J
BMC Neurol; 2019 Dec; 19(1):330. PubMed ID: 31852447
[TBL] [Abstract][Full Text] [Related]
14. Neonatal metabolic myopathies.
Tein I
Semin Perinatol; 1999 Apr; 23(2):125-51. PubMed ID: 10331465
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. State of the art in muscle lipid diseases.
Liang WC; Nishino I
Acta Myol; 2010 Oct; 29(2):351-6. PubMed ID: 21314018
[TBL] [Abstract][Full Text] [Related]
17. Lipid storage myopathies: Current treatments and future directions.
Vasiljevski ER; Summers MA; Little DG; Schindeler A
Prog Lipid Res; 2018 Oct; 72():1-17. PubMed ID: 30099045
[TBL] [Abstract][Full Text] [Related]
18. Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.
Fu HX; Liu XY; Wang ZQ; Jin M; Wang DN; He JJ; Lin MT; Wang N
Neurol Sci; 2016 Jul; 37(7):1099-105. PubMed ID: 27000805
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic significance of muscle biopsies in metabolic myopathies. II. Clinical biochemistry].
Deufel T; Paetzke I; Pongratz D; Hübner G; Wieland OH
Klin Wochenschr; 1984 Jul; 62(14):651-8. PubMed ID: 6590924
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic challenges in metabolic myopathies.
Angelini C; Marozzo R; Pegoraro V; Sacconi S
Expert Rev Neurother; 2020 Dec; 20(12):1287-1298. PubMed ID: 32941087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
